We conclude that ALL has a distinct metabolic landscape and that APR-246 sensitivity in ALL, unlike in solid tumors, is not correlated to mutant p53 or xCT expression levels. The gene discussed is SLC7A11; the disease is acute lymphoblastic leukemia.